data_2e4e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e4e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.99 -32.62 6.88 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.688 2.259 . . . . 0.0 113.046 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.76 -55.39 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m -88.01 -27.77 21.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.416 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.88 34.37 15.56 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.969 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.44 -137.71 0.37 Allowed 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -141.68 10.41 2.03 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.403 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t0 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.34 -32.29 10.45 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.657 2.238 . . . . 0.0 113.161 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.23 -54.65 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.936 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 m -90.41 -27.0 19.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.447 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.26 18.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.896 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.39 -138.6 0.34 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -129.58 6.34 5.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.258 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.131 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.452 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 7' ' ' GLY . 22.7 t0 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.82 -32.3 11.69 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.708 2.272 . . . . 0.0 113.291 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.95 -54.76 43.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.4 m -90.09 -27.99 19.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.288 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 3' ' ' ASP . . . 85.29 32.45 19.88 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.808 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.0 -138.18 0.35 Allowed 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.318 0.58 . . . . 0.0 109.598 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -134.25 7.08 3.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.394 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.177 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.504 -179.927 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -73.79 -32.9 6.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.829 2.353 . . . . 0.0 113.028 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.73 -54.61 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.6 m -89.23 -27.02 20.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.558 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.0 33.58 17.65 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.81 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.24 -137.16 0.36 Allowed 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -141.31 9.36 2.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.565 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.136 0 CA-C-O 118.389 -1.228 . . . . 0.0 112.414 179.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -73.21 -32.85 7.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.838 2.359 . . . . 0.0 113.075 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.38 -54.64 44.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -88.76 -28.27 20.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.473 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.8 33.54 18.36 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.994 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.9 -137.68 0.36 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -142.2 10.11 1.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.466 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -74.13 -32.62 6.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.769 2.313 . . . . 0.0 113.1 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.03 -56.25 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.72 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.6 m -85.55 -27.9 25.24 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.525 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.8 18.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.864 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.61 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -139.5 10.73 2.5 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.53 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.462 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -74.1 -32.54 6.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.682 2.255 . . . . 0.0 113.13 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.22 24.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.65 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 m -85.5 -28.51 24.93 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.35 33.85 18.75 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.788 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.21 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -140.88 10.49 2.2 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.516 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.089 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.514 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.23 -32.29 10.72 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.79 2.327 . . . . 0.0 113.197 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.57 -55.12 38.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.936 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -89.88 -26.01 20.7 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.0 31.56 20.07 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.862 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.0 -137.39 0.34 Allowed 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 123.209 0.604 . . . . 0.0 109.476 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -130.14 6.58 4.98 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.372 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.196 0 CA-C-N 114.252 -1.34 . . . . 0.0 112.503 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.63 -32.92 7.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.757 2.305 . . . . 0.0 113.053 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -55.25 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.789 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -84.11 -30.51 25.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.46 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 33.19 21.87 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.024 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.31 -137.53 0.36 Allowed 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -140.69 10.58 2.24 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.602 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.036 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.473 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t0 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -73.17 -33.22 7.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.73 2.287 . . . . 0.0 113.054 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.26 -55.24 36.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.739 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.8 m -81.16 -32.31 33.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.9 27.45 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.958 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.71 -137.61 0.34 Allowed 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -139.8 10.07 2.41 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.61 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.306 -1.274 . . . . 0.0 112.512 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -72.86 -33.45 7.87 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.64 2.227 . . . . 0.0 113.0 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.61 -55.3 35.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.8 m -79.95 -31.96 39.99 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.388 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.0 31.64 31.45 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.019 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.13 -137.28 0.32 Allowed 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -139.67 9.8 2.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.557 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.127 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.533 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -73.51 -32.97 7.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 113.052 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.55 32.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 m -82.77 -30.06 29.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.418 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.84 24.99 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.874 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.51 -137.2 0.35 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.27 9.86 2.52 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.543 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.102 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.526 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 120.683 0.277 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.42 -26.29 27.62 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 113.082 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.53 -55.27 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.076 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -94.59 -24.24 17.3 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.72 13.91 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.801 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.27 -137.46 0.35 Allowed 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.35 10.59 2.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.552 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.91 -33.02 12.84 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.556 2.171 . . . . 0.0 113.044 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.75 41.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.964 0.412 . . . . 0.0 110.701 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.2 m -85.02 -29.72 24.74 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.64 31.51 29.81 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.911 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.85 -137.55 0.29 Allowed 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.45 6.81 3.83 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.249 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.288 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.579 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -73.48 -32.99 7.34 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.764 2.31 . . . . 0.0 113.005 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.82 -55.36 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.75 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -83.97 -30.63 26.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 33.09 22.67 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.975 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.17 -138.05 0.36 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -140.38 10.46 2.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.483 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.434 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.74 -33.01 6.91 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.657 2.238 . . . . 0.0 112.964 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.4 -55.76 29.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 110.731 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.5 m -81.93 -30.71 31.66 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.357 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.38 24.78 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.159 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.34 -137.49 0.36 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -139.01 10.28 2.59 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.608 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.066 0 CA-C-N 114.493 -1.23 . . . . 0.0 112.454 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 7' ' ' GLY . 5.1 t70 . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -72.48 -31.82 10.7 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.629 2.219 . . . . 0.0 113.182 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.74 -54.18 50.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 m -93.67 -25.73 17.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 3' ' ' ASP . . . 86.35 33.28 14.38 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.826 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.29 -138.57 0.37 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.348 0.594 . . . . 0.0 109.493 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.75 6.58 3.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.378 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.095 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.413 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.2 t0 . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -73.08 -32.69 8.31 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.725 2.283 . . . . 0.0 113.126 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -56.02 27.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.8 m -85.49 -29.46 24.25 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.393 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.3 22.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.97 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 -137.28 0.36 Allowed 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.14 10.01 2.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.333 -1.26 . . . . 0.0 112.54 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t70 . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -74.09 -32.78 6.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.822 2.348 . . . . 0.0 113.047 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -55.42 34.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.706 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.0 m -86.17 -28.74 23.75 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.439 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 33.69 18.28 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.078 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 -138.0 0.37 Allowed 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -139.79 10.89 2.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.7 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.129 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.465 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.31 -33.1 7.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.619 2.213 . . . . 0.0 112.982 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.14 -54.86 40.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.5 m -83.71 -30.34 26.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.421 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.97 32.09 24.54 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.995 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.0 -137.18 0.34 Allowed 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.39 9.51 2.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.457 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.073 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.445 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -73.71 -32.37 7.61 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.767 2.311 . . . . 0.0 113.288 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -54.59 45.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.1 m -92.83 -24.84 18.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.597 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.43 34.72 15.93 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.819 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.95 -137.86 0.37 Allowed 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -144.25 10.25 1.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.556 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.121 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.495 179.995 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t70 . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -73.73 -32.79 7.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.674 2.25 . . . . 0.0 113.094 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.65 -55.59 32.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.701 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m -84.92 -30.01 24.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.385 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.32 33.29 20.47 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 -137.9 0.37 Allowed 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -140.13 10.23 2.35 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.599 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.169 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 179.969 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t0 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.32 -26.89 28.85 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.496 2.131 . . . . 0.0 112.865 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.96 38.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.881 0.372 . . . . 0.0 111.221 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.7 m -90.77 -25.6 19.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.73 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.92 16.85 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.872 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.32 -137.53 0.33 Allowed 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -136.25 10.29 3.25 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.508 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.093 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.464 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.431 -0.267 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.526 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.6 t80 -61.45 129.84 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.843 0.354 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -90.95 103.99 8.41 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.863 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.8 Cg_exo -73.99 -32.62 6.88 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.688 2.259 . . . . 0.0 113.046 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.76 -55.39 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m -88.01 -27.77 21.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.416 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.88 34.37 15.56 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.969 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.449 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -113.44 -137.71 0.37 Allowed 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -141.68 10.41 2.03 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.403 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.555 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.3 t80 -59.99 129.01 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 110.984 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -87.33 104.44 6.29 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.605 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 16.9 Cg_exo -72.34 -32.29 10.45 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.657 2.238 . . . . 0.0 113.161 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.23 -54.65 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.936 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 m -90.41 -27.0 19.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.447 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.26 18.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.896 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.441 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -119.39 -138.6 0.34 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -129.58 6.34 5.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.258 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.131 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.452 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.552 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.5 t80 -59.55 128.72 38.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.738 0.304 . . . . 0.0 111.006 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 7' ' ' GLY . 22.7 t0 -86.94 104.59 6.25 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.541 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 17.1 Cg_exo -71.82 -32.3 11.69 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.708 2.272 . . . . 0.0 113.291 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.95 -54.76 43.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.4 m -90.09 -27.99 19.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.288 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 3' ' ' ASP . . . 85.29 32.45 19.88 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.808 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.43 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -119.0 -138.18 0.35 Allowed 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.318 0.58 . . . . 0.0 109.598 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -134.25 7.08 3.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.394 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.177 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.504 -179.927 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.531 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.5 t80 -62.98 129.94 42.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.093 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.56 104.13 8.39 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.869 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.4 Cg_exo -73.79 -32.9 6.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.829 2.353 . . . . 0.0 113.028 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.73 -54.61 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.6 m -89.23 -27.02 20.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.558 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.0 33.58 17.65 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.81 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.437 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -115.24 -137.16 0.36 Allowed 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -141.31 9.36 2.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.565 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.136 0 CA-C-O 118.389 -1.228 . . . . 0.0 112.414 179.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.539 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.8 t80 -61.6 129.58 41.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.691 0.282 . . . . 0.0 111.04 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -89.54 104.07 7.37 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.842 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.8 Cg_exo -73.21 -32.85 7.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.838 2.359 . . . . 0.0 113.075 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.38 -54.64 44.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -88.76 -28.27 20.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.473 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.8 33.54 18.36 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.994 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.443 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -115.9 -137.68 0.36 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -142.2 10.11 1.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.466 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.498 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 80.5 t80 -62.79 130.15 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.022 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -92.66 104.12 10.59 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.944 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.3 Cg_exo -74.13 -32.62 6.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.769 2.313 . . . . 0.0 113.1 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.03 -56.25 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.72 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.6 m -85.55 -27.9 25.24 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.525 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.8 18.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.864 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.433 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -112.61 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -139.5 10.73 2.5 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.53 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.462 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.504 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 82.1 t80 -60.61 130.0 44.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 111.063 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -91.59 104.39 10.05 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.844 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.6 Cg_exo -74.1 -32.54 6.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.682 2.255 . . . . 0.0 113.13 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.22 24.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.65 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 m -85.5 -28.51 24.93 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.35 33.85 18.75 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.788 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.438 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -113.21 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -140.88 10.49 2.2 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.516 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.089 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.514 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.555 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 87.1 t80 -61.56 129.24 40.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.699 0.285 . . . . 0.0 111.024 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -87.89 104.26 6.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.572 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 16.9 Cg_exo -72.23 -32.29 10.72 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.79 2.327 . . . . 0.0 113.197 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.57 -55.12 38.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.936 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -89.88 -26.01 20.7 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.0 31.56 20.07 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.862 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.452 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -119.0 -137.39 0.34 Allowed 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 123.209 0.604 . . . . 0.0 109.476 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -130.14 6.58 4.98 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.372 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.196 0 CA-C-N 114.252 -1.34 . . . . 0.0 112.503 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.527 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.2 t80 -61.16 129.83 43.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.766 0.317 . . . . 0.0 110.963 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -90.38 104.16 8.29 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.1 Cg_exo -73.63 -32.92 7.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.757 2.305 . . . . 0.0 113.053 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -55.25 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.789 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.2 m -84.11 -30.51 25.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.46 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 33.19 21.87 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.024 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.444 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -116.31 -137.53 0.36 Allowed 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -140.69 10.58 2.24 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.602 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.036 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.473 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.527 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.2 t80 -59.76 129.75 43.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -89.8 104.4 8.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.737 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.9 Cg_exo -73.17 -33.22 7.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.73 2.287 . . . . 0.0 113.054 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.26 -55.24 36.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.739 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.8 m -81.16 -32.31 33.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.9 27.45 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.958 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -119.71 -137.61 0.34 Allowed 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -139.8 10.07 2.41 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.61 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.306 -1.274 . . . . 0.0 112.512 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.529 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.0 t80 -60.89 129.65 42.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.756 0.312 . . . . 0.0 111.075 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -89.85 104.29 8.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.726 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 16.0 Cg_exo -72.86 -33.45 7.87 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.64 2.227 . . . . 0.0 113.0 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.61 -55.3 35.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.8 m -79.95 -31.96 39.99 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.388 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.0 31.64 31.45 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.019 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.42 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.3 OUTLIER -121.13 -137.28 0.32 Allowed 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -139.67 9.8 2.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.557 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.127 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.533 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.52 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.2 t80 -61.81 129.96 43.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 111.04 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -90.64 104.23 8.68 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.778 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.6 Cg_exo -73.51 -32.97 7.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 113.052 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.55 32.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.4 m -82.77 -30.06 29.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.418 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.84 24.99 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.874 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.443 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -118.51 -137.2 0.35 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.27 9.86 2.52 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.543 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.102 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.526 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 8' ' ' THR . 34.9 t80 -70.91 155.4 40.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.234 0.54 . . . . 0.0 111.06 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -120.03 80.48 26.67 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.357 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.42 -26.29 27.62 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 113.082 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.53 -55.27 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.076 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.0 m -94.59 -24.24 17.3 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.72 13.91 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.801 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.405 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -118.27 -137.46 0.35 Allowed 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.35 10.59 2.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.552 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.569 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.0 t80 -59.7 128.37 36.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.651 0.262 . . . . 0.0 111.059 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -86.66 104.36 5.68 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 17.3 Cg_exo -70.91 -33.02 12.84 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.556 2.171 . . . . 0.0 113.044 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.75 41.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.964 0.412 . . . . 0.0 110.701 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.2 m -85.02 -29.72 24.74 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.64 31.51 29.81 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.911 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.412 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.3 OUTLIER -123.85 -137.55 0.29 Allowed 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.45 6.81 3.83 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.249 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.288 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.579 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.527 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.3 t80 -60.78 129.72 42.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.767 0.318 . . . . 0.0 110.969 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.4 104.15 8.3 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.889 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.3 Cg_exo -73.48 -32.99 7.34 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.764 2.31 . . . . 0.0 113.005 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.82 -55.36 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.75 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -83.97 -30.63 26.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 33.09 22.67 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.975 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.446 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -116.17 -138.05 0.36 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -140.38 10.46 2.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.483 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.434 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.3 t80 -61.23 129.68 42.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.734 0.302 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -90.95 104.32 9.16 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.775 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.2 Cg_exo -73.74 -33.01 6.91 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.657 2.238 . . . . 0.0 112.964 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.4 -55.76 29.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 110.731 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.5 m -81.93 -30.71 31.66 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.357 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.38 24.78 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.159 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.442 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -117.34 -137.49 0.36 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -139.01 10.28 2.59 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.608 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.066 0 CA-C-N 114.493 -1.23 . . . . 0.0 112.454 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.553 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.8 t80 -60.21 129.05 39.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.681 0.277 . . . . 0.0 111.014 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 7' ' ' GLY . 5.1 t70 -87.36 104.46 6.35 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.532 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 17.1 Cg_exo -72.48 -31.82 10.7 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.629 2.219 . . . . 0.0 113.182 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.74 -54.18 50.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 m -93.67 -25.73 17.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 3' ' ' ASP . . . 86.35 33.28 14.38 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.826 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.451 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -116.29 -138.57 0.37 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.348 0.594 . . . . 0.0 109.493 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.75 6.58 3.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.378 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.095 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.413 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.543 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.6 t80 -61.54 129.52 41.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.688 0.28 . . . . 0.0 111.042 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.49 104.12 7.42 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.769 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.9 Cg_exo -73.08 -32.69 8.31 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.725 2.283 . . . . 0.0 113.126 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -56.02 27.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.8 m -85.49 -29.46 24.25 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.393 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.3 22.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.97 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.438 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -117.18 -137.28 0.36 Allowed 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.14 10.01 2.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.333 -1.26 . . . . 0.0 112.54 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.509 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 82.0 t80 -60.52 129.57 42.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.733 0.301 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -91.77 104.24 9.88 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.846 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.4 Cg_exo -74.09 -32.78 6.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.822 2.348 . . . . 0.0 113.047 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -55.42 34.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.706 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.0 m -86.17 -28.74 23.75 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.439 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 33.69 18.28 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.078 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -113.18 -138.0 0.37 Allowed 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -139.79 10.89 2.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.7 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.129 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.465 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.529 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.7 t80 -62.46 129.74 42.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.71 0.29 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -90.29 104.07 8.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.848 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.5 Cg_exo -73.31 -33.1 7.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.619 2.213 . . . . 0.0 112.982 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.14 -54.86 40.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.5 m -83.71 -30.34 26.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.421 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.97 32.09 24.54 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.995 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.444 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -119.0 -137.18 0.34 Allowed 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.39 9.51 2.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.457 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.073 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.445 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.535 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.5 t80 -63.69 129.77 41.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.627 0.251 . . . . 0.0 111.044 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -89.86 104.1 7.7 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.77 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.3 Cg_exo -73.71 -32.37 7.61 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.767 2.311 . . . . 0.0 113.288 -178.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -54.59 45.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.1 m -92.83 -24.84 18.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.597 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.43 34.72 15.93 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.819 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.431 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -110.95 -137.86 0.37 Allowed 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -144.25 10.25 1.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.556 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.121 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.495 179.995 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.524 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.1 t80 -62.03 129.76 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.312 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.92 104.13 8.69 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.848 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.9 Cg_exo -73.73 -32.79 7.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.674 2.25 . . . . 0.0 113.094 -178.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.65 -55.59 32.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.701 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m -84.92 -30.01 24.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.385 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.32 33.29 20.47 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.45 ' O ' ' CD1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -115.13 -137.9 0.37 Allowed 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.618 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -140.13 10.23 2.35 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.599 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.169 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 179.969 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.417 ' CE1' ' O ' ' A' ' 8' ' ' THR . 30.7 t80 -70.83 152.85 43.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.211 0.529 . . . . 0.0 111.061 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -119.2 80.75 20.3 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.183 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.32 -26.89 28.85 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.496 2.131 . . . . 0.0 112.865 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.96 38.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.881 0.372 . . . . 0.0 111.221 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.7 m -90.77 -25.6 19.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.73 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.92 16.85 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.872 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.417 ' O ' ' CE1' ' A' ' 2' ' ' TYR . 0.2 OUTLIER -120.32 -137.53 0.33 Allowed 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.877 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 15.5 m-85 -136.25 10.29 3.25 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.508 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.093 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.464 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.99 -32.62 6.88 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.688 2.259 . . . . 0.0 113.046 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.76 -55.39 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.579 HG22 ' OG1' ' A' ' 8' ' ' THR . 16.8 m -88.01 -27.77 21.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.416 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.88 34.37 15.56 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.969 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.579 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.44 -137.71 0.37 Allowed 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -141.68 10.41 2.03 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.403 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t0 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.34 -32.29 10.45 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.657 2.238 . . . . 0.0 113.161 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.23 -54.65 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.936 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.651 HG22 ' OG1' ' A' ' 8' ' ' THR . 12.9 m -90.41 -27.0 19.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.447 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.26 18.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.896 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.651 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.39 -138.6 0.34 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -129.58 6.34 5.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.258 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.131 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.452 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t0 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.82 -32.3 11.69 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.708 2.272 . . . . 0.0 113.291 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.95 -54.76 43.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.671 HG22 ' OG1' ' A' ' 8' ' ' THR . 17.4 m -90.09 -27.99 19.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.288 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.29 32.45 19.88 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.808 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.671 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -138.18 0.35 Allowed 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.318 0.58 . . . . 0.0 109.598 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -134.25 7.08 3.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.394 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.177 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.504 -179.927 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -73.79 -32.9 6.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.829 2.353 . . . . 0.0 113.028 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.73 -54.61 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.624 HG22 ' OG1' ' A' ' 8' ' ' THR . 15.6 m -89.23 -27.02 20.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.558 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.0 33.58 17.65 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.81 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.624 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.24 -137.16 0.36 Allowed 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -141.31 9.36 2.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.565 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.136 0 CA-C-O 118.389 -1.228 . . . . 0.0 112.414 179.935 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -73.21 -32.85 7.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.838 2.359 . . . . 0.0 113.075 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.38 -54.64 44.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.624 HG22 ' OG1' ' A' ' 8' ' ' THR . 17.9 m -88.76 -28.27 20.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.473 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.8 33.54 18.36 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.994 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.624 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.9 -137.68 0.36 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -142.2 10.11 1.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.466 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -74.13 -32.62 6.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.769 2.313 . . . . 0.0 113.1 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.03 -56.25 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.72 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.6 HG22 ' OG1' ' A' ' 8' ' ' THR . 18.6 m -85.55 -27.9 25.24 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.525 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.8 18.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.864 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.6 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -112.61 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -139.5 10.73 2.5 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.53 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.462 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -74.1 -32.54 6.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.682 2.255 . . . . 0.0 113.13 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.22 24.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.65 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.612 HG22 ' OG1' ' A' ' 8' ' ' THR . 21.2 m -85.5 -28.51 24.93 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.35 33.85 18.75 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.788 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.21 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -140.88 10.49 2.2 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.516 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.089 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.514 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.23 -32.29 10.72 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.79 2.327 . . . . 0.0 113.197 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.57 -55.12 38.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.936 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.646 HG22 ' OG1' ' A' ' 8' ' ' THR . 9.3 m -89.88 -26.01 20.7 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.0 31.56 20.07 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.862 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.646 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -137.39 0.34 Allowed 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 123.209 0.604 . . . . 0.0 109.476 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -130.14 6.58 4.98 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.372 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.196 0 CA-C-N 114.252 -1.34 . . . . 0.0 112.503 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.63 -32.92 7.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.757 2.305 . . . . 0.0 113.053 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -55.25 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.789 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.665 HG22 ' OG1' ' A' ' 8' ' ' THR . 25.2 m -84.11 -30.51 25.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.46 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 33.19 21.87 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.024 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.665 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.31 -137.53 0.36 Allowed 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -140.69 10.58 2.24 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.602 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.036 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.473 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t0 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -73.17 -33.22 7.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.73 2.287 . . . . 0.0 113.054 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.26 -55.24 36.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.739 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.716 HG22 ' OG1' ' A' ' 8' ' ' THR . 44.8 m -81.16 -32.31 33.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.9 27.45 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.958 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.716 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.71 -137.61 0.34 Allowed 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -139.8 10.07 2.41 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.61 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.306 -1.274 . . . . 0.0 112.512 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -72.86 -33.45 7.87 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.64 2.227 . . . . 0.0 113.0 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.61 -55.3 35.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.756 HG22 ' OG1' ' A' ' 8' ' ' THR . 35.8 m -79.95 -31.96 39.99 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.388 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.0 31.64 31.45 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.019 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.756 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -121.13 -137.28 0.32 Allowed 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -139.67 9.8 2.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.557 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.127 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.533 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -73.51 -32.97 7.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 113.052 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.55 32.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.704 HG22 ' OG1' ' A' ' 8' ' ' THR . 24.4 m -82.77 -30.06 29.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.418 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.84 24.99 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.874 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.704 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -118.51 -137.2 0.35 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.27 9.86 2.52 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.543 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.102 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.526 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 120.683 0.277 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.42 -26.29 27.62 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 113.082 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.53 -55.27 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.076 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.55 HG22 ' OG1' ' A' ' 8' ' ' THR . 5.0 m -94.59 -24.24 17.3 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.72 13.91 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.801 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.55 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -118.27 -137.46 0.35 Allowed 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.35 10.59 2.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.552 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.91 -33.02 12.84 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.556 2.171 . . . . 0.0 113.044 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.75 41.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.964 0.412 . . . . 0.0 110.701 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.751 HG22 ' OG1' ' A' ' 8' ' ' THR . 18.2 m -85.02 -29.72 24.74 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.64 31.51 29.81 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.911 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.751 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -123.85 -137.55 0.29 Allowed 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.45 6.81 3.83 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.249 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.288 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.579 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -73.48 -32.99 7.34 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.764 2.31 . . . . 0.0 113.005 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.82 -55.36 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.75 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.671 HG22 ' OG1' ' A' ' 8' ' ' THR . 28.3 m -83.97 -30.63 26.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 33.09 22.67 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.975 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.671 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.17 -138.05 0.36 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -140.38 10.46 2.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.483 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.434 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.74 -33.01 6.91 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.657 2.238 . . . . 0.0 112.964 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.4 -55.76 29.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 110.731 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.677 HG22 ' OG1' ' A' ' 8' ' ' THR . 32.5 m -81.93 -30.71 31.66 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.357 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.38 24.78 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.159 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.677 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -117.34 -137.49 0.36 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -139.01 10.28 2.59 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.608 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.066 0 CA-C-N 114.493 -1.23 . . . . 0.0 112.454 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -72.48 -31.82 10.7 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.629 2.219 . . . . 0.0 113.182 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.74 -54.18 50.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.593 HG22 ' OG1' ' A' ' 8' ' ' THR . 8.9 m -93.67 -25.73 17.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.53 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.35 33.28 14.38 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.826 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.29 -138.57 0.37 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.348 0.594 . . . . 0.0 109.493 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.75 6.58 3.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.378 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.095 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.413 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.2 t0 . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -73.08 -32.69 8.31 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.725 2.283 . . . . 0.0 113.126 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -56.02 27.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.663 HG22 ' OG1' ' A' ' 8' ' ' THR . 21.8 m -85.49 -29.46 24.25 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.393 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.3 22.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.97 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.663 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -117.18 -137.28 0.36 Allowed 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.14 10.01 2.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.333 -1.26 . . . . 0.0 112.54 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t70 . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -74.09 -32.78 6.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.822 2.348 . . . . 0.0 113.047 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -55.42 34.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.706 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.58 HG22 ' OG1' ' A' ' 8' ' ' THR . 20.0 m -86.17 -28.74 23.75 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.439 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 33.69 18.28 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.078 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.58 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.18 -138.0 0.37 Allowed 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -139.79 10.89 2.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.7 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.129 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.465 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.31 -33.1 7.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.619 2.213 . . . . 0.0 112.982 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.14 -54.86 40.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.719 HG22 ' OG1' ' A' ' 8' ' ' THR . 22.5 m -83.71 -30.34 26.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.421 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.97 32.09 24.54 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.995 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.719 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -137.18 0.34 Allowed 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.39 9.51 2.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.457 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.073 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.445 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -73.71 -32.37 7.61 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.767 2.311 . . . . 0.0 113.288 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -54.59 45.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.566 HG22 ' OG1' ' A' ' 8' ' ' THR . 6.1 m -92.83 -24.84 18.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.597 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.43 34.72 15.93 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.819 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.566 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -110.95 -137.86 0.37 Allowed 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -144.25 10.25 1.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.556 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.121 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.495 179.995 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t70 . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -73.73 -32.79 7.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.674 2.25 . . . . 0.0 113.094 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.65 -55.59 32.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.701 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.61 HG22 ' OG1' ' A' ' 8' ' ' THR . 24.6 m -84.92 -30.01 24.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.385 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.32 33.29 20.47 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.61 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.13 -137.9 0.37 Allowed 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.618 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -140.13 10.23 2.35 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.599 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.169 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 179.969 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t0 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.32 -26.89 28.85 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.496 2.131 . . . . 0.0 112.865 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.96 38.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.881 0.372 . . . . 0.0 111.221 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.608 HG22 ' OG1' ' A' ' 8' ' ' THR . 7.7 m -90.77 -25.6 19.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.92 16.85 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.872 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -120.32 -137.53 0.33 Allowed 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.877 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -136.25 10.29 3.25 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.508 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.093 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.464 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.431 -0.267 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.6 t80 -61.45 129.84 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.843 0.354 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -90.95 103.99 8.41 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.863 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.8 Cg_exo -73.99 -32.62 6.88 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.688 2.259 . . . . 0.0 113.046 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.76 -55.39 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.579 HG22 ' OG1' ' A' ' 8' ' ' THR . 16.8 m -88.01 -27.77 21.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.416 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.88 34.37 15.56 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.969 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.579 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.44 -137.71 0.37 Allowed 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -141.68 10.41 2.03 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.403 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.538 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.3 t80 -59.99 129.01 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 110.984 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -87.33 104.44 6.29 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.605 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 16.9 Cg_exo -72.34 -32.29 10.45 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.657 2.238 . . . . 0.0 113.161 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.23 -54.65 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.936 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.651 HG22 ' OG1' ' A' ' 8' ' ' THR . 12.9 m -90.41 -27.0 19.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.447 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.26 18.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.896 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.651 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.39 -138.6 0.34 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -129.58 6.34 5.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.258 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.131 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.452 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.534 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.5 t80 -59.55 128.72 38.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.738 0.304 . . . . 0.0 111.006 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -86.94 104.59 6.25 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.541 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 17.1 Cg_exo -71.82 -32.3 11.69 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.708 2.272 . . . . 0.0 113.291 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.95 -54.76 43.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.671 HG22 ' OG1' ' A' ' 8' ' ' THR . 17.4 m -90.09 -27.99 19.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.288 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.29 32.45 19.88 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.808 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.671 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -138.18 0.35 Allowed 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.318 0.58 . . . . 0.0 109.598 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -134.25 7.08 3.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.394 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.177 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.504 -179.927 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.519 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.5 t80 -62.98 129.94 42.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.093 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.56 104.13 8.39 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.869 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.4 Cg_exo -73.79 -32.9 6.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.829 2.353 . . . . 0.0 113.028 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.73 -54.61 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.624 HG22 ' OG1' ' A' ' 8' ' ' THR . 15.6 m -89.23 -27.02 20.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.558 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.0 33.58 17.65 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.81 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.624 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.24 -137.16 0.36 Allowed 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -141.31 9.36 2.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.565 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.136 0 CA-C-O 118.389 -1.228 . . . . 0.0 112.414 179.935 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.532 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.8 t80 -61.6 129.58 41.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.691 0.282 . . . . 0.0 111.04 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -89.54 104.07 7.37 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.842 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.8 Cg_exo -73.21 -32.85 7.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.838 2.359 . . . . 0.0 113.075 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.38 -54.64 44.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.624 HG22 ' OG1' ' A' ' 8' ' ' THR . 17.9 m -88.76 -28.27 20.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.473 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.8 33.54 18.36 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.994 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.624 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.9 -137.68 0.36 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -142.2 10.11 1.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.466 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.494 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 80.5 t80 -62.79 130.15 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.022 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -92.66 104.12 10.59 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.944 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.3 Cg_exo -74.13 -32.62 6.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.769 2.313 . . . . 0.0 113.1 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.03 -56.25 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.72 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.6 HG22 ' OG1' ' A' ' 8' ' ' THR . 18.6 m -85.55 -27.9 25.24 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.525 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.8 18.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.864 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.6 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -112.61 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 17.9 m-85 -139.5 10.73 2.5 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.53 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.462 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.498 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 82.1 t80 -60.61 130.0 44.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 111.063 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -91.59 104.39 10.05 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.844 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.6 Cg_exo -74.1 -32.54 6.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.682 2.255 . . . . 0.0 113.13 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.22 24.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.65 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.612 HG22 ' OG1' ' A' ' 8' ' ' THR . 21.2 m -85.5 -28.51 24.93 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.35 33.85 18.75 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.788 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.21 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -140.88 10.49 2.2 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.516 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.089 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.514 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.539 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 87.1 t80 -61.56 129.24 40.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.699 0.285 . . . . 0.0 111.024 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -87.89 104.26 6.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.572 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 16.9 Cg_exo -72.23 -32.29 10.72 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.79 2.327 . . . . 0.0 113.197 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.57 -55.12 38.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.936 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.646 HG22 ' OG1' ' A' ' 8' ' ' THR . 9.3 m -89.88 -26.01 20.7 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.0 31.56 20.07 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.862 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.646 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -137.39 0.34 Allowed 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 123.209 0.604 . . . . 0.0 109.476 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -130.14 6.58 4.98 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.372 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.196 0 CA-C-N 114.252 -1.34 . . . . 0.0 112.503 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.521 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.2 t80 -61.16 129.83 43.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.766 0.317 . . . . 0.0 110.963 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -90.38 104.16 8.29 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.1 Cg_exo -73.63 -32.92 7.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.757 2.305 . . . . 0.0 113.053 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -55.25 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.789 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.665 HG22 ' OG1' ' A' ' 8' ' ' THR . 25.2 m -84.11 -30.51 25.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.46 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 33.19 21.87 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.024 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.665 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.31 -137.53 0.36 Allowed 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -140.69 10.58 2.24 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.602 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.036 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.473 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.2 t80 -59.76 129.75 43.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -89.8 104.4 8.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.737 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.9 Cg_exo -73.17 -33.22 7.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.73 2.287 . . . . 0.0 113.054 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.26 -55.24 36.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.739 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.716 HG22 ' OG1' ' A' ' 8' ' ' THR . 44.8 m -81.16 -32.31 33.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.9 27.45 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.958 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.716 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.71 -137.61 0.34 Allowed 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -139.8 10.07 2.41 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.61 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.306 -1.274 . . . . 0.0 112.512 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.523 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.0 t80 -60.89 129.65 42.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.756 0.312 . . . . 0.0 111.075 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -89.85 104.29 8.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.726 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 16.0 Cg_exo -72.86 -33.45 7.87 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.64 2.227 . . . . 0.0 113.0 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.61 -55.3 35.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.756 HG22 ' OG1' ' A' ' 8' ' ' THR . 35.8 m -79.95 -31.96 39.99 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.388 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.0 31.64 31.45 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.019 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.756 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -121.13 -137.28 0.32 Allowed 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -139.67 9.8 2.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.557 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.127 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.533 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.515 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.2 t80 -61.81 129.96 43.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 111.04 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -90.64 104.23 8.68 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.778 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.6 Cg_exo -73.51 -32.97 7.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 113.052 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.55 32.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.704 HG22 ' OG1' ' A' ' 8' ' ' THR . 24.4 m -82.77 -30.06 29.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.418 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.84 24.99 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.874 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.704 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -118.51 -137.2 0.35 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.27 9.86 2.52 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.543 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.102 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.526 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 34.9 t80 -70.91 155.4 40.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.234 0.54 . . . . 0.0 111.06 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -120.03 80.48 26.67 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.357 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.42 -26.29 27.62 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 113.082 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.53 -55.27 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.076 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.55 HG22 ' OG1' ' A' ' 8' ' ' THR . 5.0 m -94.59 -24.24 17.3 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.72 13.91 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.801 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.55 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -118.27 -137.46 0.35 Allowed 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 18.8 m-85 -137.35 10.59 2.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.552 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.553 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.0 t80 -59.7 128.37 36.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.651 0.262 . . . . 0.0 111.059 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -86.66 104.36 5.68 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 17.3 Cg_exo -70.91 -33.02 12.84 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.556 2.171 . . . . 0.0 113.044 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.75 41.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.964 0.412 . . . . 0.0 110.701 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.751 HG22 ' OG1' ' A' ' 8' ' ' THR . 18.2 m -85.02 -29.72 24.74 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.64 31.51 29.81 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.911 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.751 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -123.85 -137.55 0.29 Allowed 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.45 6.81 3.83 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.249 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.288 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.579 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.522 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.3 t80 -60.78 129.72 42.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.767 0.318 . . . . 0.0 110.969 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.4 104.15 8.3 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.889 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.3 Cg_exo -73.48 -32.99 7.34 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.764 2.31 . . . . 0.0 113.005 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.82 -55.36 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.75 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.671 HG22 ' OG1' ' A' ' 8' ' ' THR . 28.3 m -83.97 -30.63 26.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 33.09 22.67 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.975 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.671 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.17 -138.05 0.36 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -140.38 10.46 2.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.483 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.434 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.511 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.3 t80 -61.23 129.68 42.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.734 0.302 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -90.95 104.32 9.16 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.775 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.2 Cg_exo -73.74 -33.01 6.91 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.657 2.238 . . . . 0.0 112.964 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.4 -55.76 29.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 110.731 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.677 HG22 ' OG1' ' A' ' 8' ' ' THR . 32.5 m -81.93 -30.71 31.66 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.357 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.38 24.78 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.159 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.677 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -117.34 -137.49 0.36 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -139.01 10.28 2.59 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.608 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.066 0 CA-C-N 114.493 -1.23 . . . . 0.0 112.454 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.534 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.8 t80 -60.21 129.05 39.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.681 0.277 . . . . 0.0 111.014 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.36 104.46 6.35 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.532 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 17.1 Cg_exo -72.48 -31.82 10.7 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.629 2.219 . . . . 0.0 113.182 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.74 -54.18 50.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.593 HG22 ' OG1' ' A' ' 8' ' ' THR . 8.9 m -93.67 -25.73 17.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.53 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.35 33.28 14.38 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.826 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.29 -138.57 0.37 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.348 0.594 . . . . 0.0 109.493 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.75 6.58 3.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.378 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.095 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.413 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.533 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.6 t80 -61.54 129.52 41.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.688 0.28 . . . . 0.0 111.042 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.49 104.12 7.42 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.769 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.9 Cg_exo -73.08 -32.69 8.31 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.725 2.283 . . . . 0.0 113.126 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -56.02 27.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.663 HG22 ' OG1' ' A' ' 8' ' ' THR . 21.8 m -85.49 -29.46 24.25 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.393 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.3 22.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.97 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.663 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -117.18 -137.28 0.36 Allowed 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.14 10.01 2.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.333 -1.26 . . . . 0.0 112.54 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.505 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 82.0 t80 -60.52 129.57 42.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.733 0.301 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -91.77 104.24 9.88 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.846 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.4 Cg_exo -74.09 -32.78 6.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.822 2.348 . . . . 0.0 113.047 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -55.42 34.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.706 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.58 HG22 ' OG1' ' A' ' 8' ' ' THR . 20.0 m -86.17 -28.74 23.75 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.439 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 33.69 18.28 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.078 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.58 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.18 -138.0 0.37 Allowed 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -139.79 10.89 2.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.7 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.129 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.465 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.524 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.7 t80 -62.46 129.74 42.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.71 0.29 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -90.29 104.07 8.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.848 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.5 Cg_exo -73.31 -33.1 7.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.619 2.213 . . . . 0.0 112.982 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.14 -54.86 40.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.719 HG22 ' OG1' ' A' ' 8' ' ' THR . 22.5 m -83.71 -30.34 26.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.421 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.97 32.09 24.54 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.995 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.719 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -137.18 0.34 Allowed 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.39 9.51 2.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.457 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.073 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.445 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.528 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.5 t80 -63.69 129.77 41.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.627 0.251 . . . . 0.0 111.044 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -89.86 104.1 7.7 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.77 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.3 Cg_exo -73.71 -32.37 7.61 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.767 2.311 . . . . 0.0 113.288 -178.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -54.59 45.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.566 HG22 ' OG1' ' A' ' 8' ' ' THR . 6.1 m -92.83 -24.84 18.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.597 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.43 34.72 15.93 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.819 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.566 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -110.95 -137.86 0.37 Allowed 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 12.3 m-85 -144.25 10.25 1.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.556 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.121 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.495 179.995 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.1 t80 -62.03 129.76 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.312 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.92 104.13 8.69 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.848 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.9 Cg_exo -73.73 -32.79 7.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.674 2.25 . . . . 0.0 113.094 -178.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.65 -55.59 32.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.701 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.61 HG22 ' OG1' ' A' ' 8' ' ' THR . 24.6 m -84.92 -30.01 24.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.385 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.32 33.29 20.47 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.61 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.13 -137.9 0.37 Allowed 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.618 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -140.13 10.23 2.35 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.599 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.169 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 179.969 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 30.7 t80 -70.83 152.85 43.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.211 0.529 . . . . 0.0 111.061 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -119.2 80.75 20.3 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.183 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.32 -26.89 28.85 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.496 2.131 . . . . 0.0 112.865 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.96 38.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.881 0.372 . . . . 0.0 111.221 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.608 HG22 ' OG1' ' A' ' 8' ' ' THR . 7.7 m -90.77 -25.6 19.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.92 16.85 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.872 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -120.32 -137.53 0.33 Allowed 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.877 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 15.5 m-85 -136.25 10.29 3.25 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.508 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.093 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.464 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.99 -32.62 6.88 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.688 2.259 . . . . 0.0 113.046 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.76 -55.39 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.579 HG22 ' OG1' ' A' ' 8' ' ' THR . 16.8 m -88.01 -27.77 21.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.416 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.88 34.37 15.56 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.969 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.579 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.44 -137.71 0.37 Allowed 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -141.68 10.41 2.03 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.403 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t0 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.34 -32.29 10.45 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.657 2.238 . . . . 0.0 113.161 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.23 -54.65 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.936 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.651 HG22 ' OG1' ' A' ' 8' ' ' THR . 12.9 m -90.41 -27.0 19.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.447 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.26 18.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.896 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.651 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.39 -138.6 0.34 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -129.58 6.34 5.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.258 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.131 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.452 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t0 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.82 -32.3 11.69 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.708 2.272 . . . . 0.0 113.291 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.95 -54.76 43.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.671 HG22 ' OG1' ' A' ' 8' ' ' THR . 17.4 m -90.09 -27.99 19.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.288 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.29 32.45 19.88 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.808 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.671 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -138.18 0.35 Allowed 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.318 0.58 . . . . 0.0 109.598 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -134.25 7.08 3.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.394 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.177 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.504 -179.927 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -73.79 -32.9 6.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.829 2.353 . . . . 0.0 113.028 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.73 -54.61 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.624 HG22 ' OG1' ' A' ' 8' ' ' THR . 15.6 m -89.23 -27.02 20.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.558 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.0 33.58 17.65 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.81 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.624 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.24 -137.16 0.36 Allowed 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -141.31 9.36 2.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.565 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.136 0 CA-C-O 118.389 -1.228 . . . . 0.0 112.414 179.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -73.21 -32.85 7.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.838 2.359 . . . . 0.0 113.075 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.38 -54.64 44.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.624 HG22 ' OG1' ' A' ' 8' ' ' THR . 17.9 m -88.76 -28.27 20.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.473 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.8 33.54 18.36 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.994 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.624 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.9 -137.68 0.36 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -142.2 10.11 1.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.466 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -74.13 -32.62 6.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.769 2.313 . . . . 0.0 113.1 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.03 -56.25 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.72 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.6 HG22 ' OG1' ' A' ' 8' ' ' THR . 18.6 m -85.55 -27.9 25.24 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.525 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.8 18.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.864 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.6 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -112.61 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -139.5 10.73 2.5 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.53 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.462 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -74.1 -32.54 6.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.682 2.255 . . . . 0.0 113.13 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.22 24.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.65 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.612 HG22 ' OG1' ' A' ' 8' ' ' THR . 21.2 m -85.5 -28.51 24.93 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.35 33.85 18.75 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.788 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.21 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -140.88 10.49 2.2 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.516 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.089 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.514 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.23 -32.29 10.72 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.79 2.327 . . . . 0.0 113.197 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.57 -55.12 38.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.936 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.646 HG22 ' OG1' ' A' ' 8' ' ' THR . 9.3 m -89.88 -26.01 20.7 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.0 31.56 20.07 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.862 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.646 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -137.39 0.34 Allowed 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 123.209 0.604 . . . . 0.0 109.476 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -130.14 6.58 4.98 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.372 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.196 0 CA-C-N 114.252 -1.34 . . . . 0.0 112.503 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.63 -32.92 7.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.757 2.305 . . . . 0.0 113.053 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -55.25 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.789 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.665 HG22 ' OG1' ' A' ' 8' ' ' THR . 25.2 m -84.11 -30.51 25.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.46 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 33.19 21.87 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.024 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.665 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.31 -137.53 0.36 Allowed 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -140.69 10.58 2.24 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.602 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.036 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.473 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t0 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -73.17 -33.22 7.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.73 2.287 . . . . 0.0 113.054 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.26 -55.24 36.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.739 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.716 HG22 ' OG1' ' A' ' 8' ' ' THR . 44.8 m -81.16 -32.31 33.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.9 27.45 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.958 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.716 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.71 -137.61 0.34 Allowed 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -139.8 10.07 2.41 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.61 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.306 -1.274 . . . . 0.0 112.512 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -72.86 -33.45 7.87 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.64 2.227 . . . . 0.0 113.0 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.61 -55.3 35.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.756 HG22 ' OG1' ' A' ' 8' ' ' THR . 35.8 m -79.95 -31.96 39.99 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.388 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.0 31.64 31.45 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.019 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.756 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -121.13 -137.28 0.32 Allowed 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -139.67 9.8 2.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.557 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.127 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.533 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -73.51 -32.97 7.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 113.052 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.55 32.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.704 HG22 ' OG1' ' A' ' 8' ' ' THR . 24.4 m -82.77 -30.06 29.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.418 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.84 24.99 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.874 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.704 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -118.51 -137.2 0.35 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.27 9.86 2.52 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.543 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.102 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.526 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 120.683 0.277 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.42 -26.29 27.62 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 113.082 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.53 -55.27 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.076 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.55 HG22 ' OG1' ' A' ' 8' ' ' THR . 5.0 m -94.59 -24.24 17.3 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.72 13.91 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.801 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.55 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -118.27 -137.46 0.35 Allowed 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.35 10.59 2.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.552 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.91 -33.02 12.84 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.556 2.171 . . . . 0.0 113.044 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.75 41.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.964 0.412 . . . . 0.0 110.701 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.751 HG22 ' OG1' ' A' ' 8' ' ' THR . 18.2 m -85.02 -29.72 24.74 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.64 31.51 29.81 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.911 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.751 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -123.85 -137.55 0.29 Allowed 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.45 6.81 3.83 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.249 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.288 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.579 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -73.48 -32.99 7.34 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.764 2.31 . . . . 0.0 113.005 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.82 -55.36 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.75 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.671 HG22 ' OG1' ' A' ' 8' ' ' THR . 28.3 m -83.97 -30.63 26.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 33.09 22.67 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.975 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.671 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.17 -138.05 0.36 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -140.38 10.46 2.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.483 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.434 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.74 -33.01 6.91 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.657 2.238 . . . . 0.0 112.964 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.4 -55.76 29.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 110.731 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.677 HG22 ' OG1' ' A' ' 8' ' ' THR . 32.5 m -81.93 -30.71 31.66 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.357 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.38 24.78 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.159 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.677 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -117.34 -137.49 0.36 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -139.01 10.28 2.59 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.608 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.066 0 CA-C-N 114.493 -1.23 . . . . 0.0 112.454 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -72.48 -31.82 10.7 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.629 2.219 . . . . 0.0 113.182 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.74 -54.18 50.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.593 HG22 ' OG1' ' A' ' 8' ' ' THR . 8.9 m -93.67 -25.73 17.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.53 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.35 33.28 14.38 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.826 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.29 -138.57 0.37 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.348 0.594 . . . . 0.0 109.493 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.75 6.58 3.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.378 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.095 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.413 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.2 t0 . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -73.08 -32.69 8.31 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.725 2.283 . . . . 0.0 113.126 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -56.02 27.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.663 HG22 ' OG1' ' A' ' 8' ' ' THR . 21.8 m -85.49 -29.46 24.25 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.393 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.3 22.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.97 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.663 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -117.18 -137.28 0.36 Allowed 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.14 10.01 2.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.333 -1.26 . . . . 0.0 112.54 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t70 . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -74.09 -32.78 6.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.822 2.348 . . . . 0.0 113.047 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -55.42 34.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.706 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.58 HG22 ' OG1' ' A' ' 8' ' ' THR . 20.0 m -86.17 -28.74 23.75 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.439 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 33.69 18.28 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.078 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.58 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.18 -138.0 0.37 Allowed 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -139.79 10.89 2.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.7 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.129 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.465 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.31 -33.1 7.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.619 2.213 . . . . 0.0 112.982 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.14 -54.86 40.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.719 HG22 ' OG1' ' A' ' 8' ' ' THR . 22.5 m -83.71 -30.34 26.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.421 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.97 32.09 24.54 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.995 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.719 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -137.18 0.34 Allowed 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.39 9.51 2.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.457 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.073 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.445 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -73.71 -32.37 7.61 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.767 2.311 . . . . 0.0 113.288 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -54.59 45.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.566 HG22 ' OG1' ' A' ' 8' ' ' THR . 6.1 m -92.83 -24.84 18.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.597 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.43 34.72 15.93 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.819 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.566 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -110.95 -137.86 0.37 Allowed 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -144.25 10.25 1.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.556 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.121 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.495 179.995 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t70 . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -73.73 -32.79 7.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.674 2.25 . . . . 0.0 113.094 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.65 -55.59 32.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.701 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.61 HG22 ' OG1' ' A' ' 8' ' ' THR . 24.6 m -84.92 -30.01 24.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.385 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.32 33.29 20.47 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.61 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.13 -137.9 0.37 Allowed 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.618 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -140.13 10.23 2.35 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.599 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.169 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 179.969 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t0 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.32 -26.89 28.85 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.496 2.131 . . . . 0.0 112.865 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.96 38.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.881 0.372 . . . . 0.0 111.221 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.608 HG22 ' OG1' ' A' ' 8' ' ' THR . 7.7 m -90.77 -25.6 19.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.92 16.85 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.872 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -120.32 -137.53 0.33 Allowed 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.877 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -136.25 10.29 3.25 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.508 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.093 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.464 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.431 -0.267 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.6 t80 -61.45 129.84 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.843 0.354 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -90.95 103.99 8.41 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.863 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.8 Cg_exo -73.99 -32.62 6.88 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.688 2.259 . . . . 0.0 113.046 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.76 -55.39 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.822 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.579 HG22 ' OG1' ' A' ' 8' ' ' THR . 16.8 m -88.01 -27.77 21.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.416 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.88 34.37 15.56 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.969 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.579 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.44 -137.71 0.37 Allowed 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -141.68 10.41 2.03 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.403 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.538 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.3 t80 -59.99 129.01 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 110.984 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -87.33 104.44 6.29 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.605 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 16.9 Cg_exo -72.34 -32.29 10.45 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.657 2.238 . . . . 0.0 113.161 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.23 -54.65 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.936 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.651 HG22 ' OG1' ' A' ' 8' ' ' THR . 12.9 m -90.41 -27.0 19.59 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.447 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.26 18.35 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.896 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.651 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.39 -138.6 0.34 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -129.58 6.34 5.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.258 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.131 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.452 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.534 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.5 t80 -59.55 128.72 38.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.738 0.304 . . . . 0.0 111.006 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -86.94 104.59 6.25 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.541 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 17.1 Cg_exo -71.82 -32.3 11.69 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.708 2.272 . . . . 0.0 113.291 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.95 -54.76 43.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.671 HG22 ' OG1' ' A' ' 8' ' ' THR . 17.4 m -90.09 -27.99 19.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.288 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.29 32.45 19.88 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.808 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.671 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -138.18 0.35 Allowed 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 121.318 0.58 . . . . 0.0 109.598 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -134.25 7.08 3.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.394 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.177 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.504 -179.927 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.519 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.5 t80 -62.98 129.94 42.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.093 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.56 104.13 8.39 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.869 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.4 Cg_exo -73.79 -32.9 6.95 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.829 2.353 . . . . 0.0 113.028 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.73 -54.61 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.624 HG22 ' OG1' ' A' ' 8' ' ' THR . 15.6 m -89.23 -27.02 20.9 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.558 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.0 33.58 17.65 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.81 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.624 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.24 -137.16 0.36 Allowed 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -141.31 9.36 2.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.565 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.136 0 CA-C-O 118.389 -1.228 . . . . 0.0 112.414 179.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.532 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.8 t80 -61.6 129.58 41.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.691 0.282 . . . . 0.0 111.04 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -89.54 104.07 7.37 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.842 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.8 Cg_exo -73.21 -32.85 7.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.838 2.359 . . . . 0.0 113.075 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.38 -54.64 44.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.624 HG22 ' OG1' ' A' ' 8' ' ' THR . 17.9 m -88.76 -28.27 20.61 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.473 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.8 33.54 18.36 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.994 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.624 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.9 -137.68 0.36 Allowed 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -142.2 10.11 1.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.36 -1.244 . . . . 0.0 112.466 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.494 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 80.5 t80 -62.79 130.15 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 0.0 111.022 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -92.66 104.12 10.59 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.944 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.3 Cg_exo -74.13 -32.62 6.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.769 2.313 . . . . 0.0 113.1 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.03 -56.25 23.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.72 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.6 HG22 ' OG1' ' A' ' 8' ' ' THR . 18.6 m -85.55 -27.9 25.24 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.525 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.8 18.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.864 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.6 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -112.61 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 17.9 m-85 -139.5 10.73 2.5 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.53 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.462 179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.498 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 82.1 t80 -60.61 130.0 44.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.758 0.313 . . . . 0.0 111.063 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -91.59 104.39 10.05 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.844 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.6 Cg_exo -74.1 -32.54 6.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.682 2.255 . . . . 0.0 113.13 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.22 24.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.65 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.612 HG22 ' OG1' ' A' ' 8' ' ' THR . 21.2 m -85.5 -28.51 24.93 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.35 33.85 18.75 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.788 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.21 -138.24 0.37 Allowed 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -140.88 10.49 2.2 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.516 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.089 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.514 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.539 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 87.1 t80 -61.56 129.24 40.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.699 0.285 . . . . 0.0 111.024 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -87.89 104.26 6.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.572 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 16.9 Cg_exo -72.23 -32.29 10.72 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.79 2.327 . . . . 0.0 113.197 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.57 -55.12 38.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.936 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.646 HG22 ' OG1' ' A' ' 8' ' ' THR . 9.3 m -89.88 -26.01 20.7 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.0 31.56 20.07 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.862 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.646 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -137.39 0.34 Allowed 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 123.209 0.604 . . . . 0.0 109.476 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -130.14 6.58 4.98 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.372 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.196 0 CA-C-N 114.252 -1.34 . . . . 0.0 112.503 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.521 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.2 t80 -61.16 129.83 43.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.766 0.317 . . . . 0.0 110.963 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -90.38 104.16 8.29 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.1 Cg_exo -73.63 -32.92 7.16 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.757 2.305 . . . . 0.0 113.053 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.08 -55.25 36.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.789 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.665 HG22 ' OG1' ' A' ' 8' ' ' THR . 25.2 m -84.11 -30.51 25.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.46 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 33.19 21.87 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.024 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.665 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.31 -137.53 0.36 Allowed 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -140.69 10.58 2.24 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.602 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.036 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.473 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.2 t80 -59.76 129.75 43.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -89.8 104.4 8.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.737 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.9 Cg_exo -73.17 -33.22 7.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.73 2.287 . . . . 0.0 113.054 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.26 -55.24 36.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.739 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.716 HG22 ' OG1' ' A' ' 8' ' ' THR . 44.8 m -81.16 -32.31 33.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.371 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.9 27.45 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.958 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.716 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.71 -137.61 0.34 Allowed 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -139.8 10.07 2.41 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.61 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.306 -1.274 . . . . 0.0 112.512 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.523 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.0 t80 -60.89 129.65 42.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.756 0.312 . . . . 0.0 111.075 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -89.85 104.29 8.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.726 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 16.0 Cg_exo -72.86 -33.45 7.87 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.64 2.227 . . . . 0.0 113.0 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.61 -55.3 35.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.756 HG22 ' OG1' ' A' ' 8' ' ' THR . 35.8 m -79.95 -31.96 39.99 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.388 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.0 31.64 31.45 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.019 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.756 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -121.13 -137.28 0.32 Allowed 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -139.67 9.8 2.43 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.557 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.127 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.533 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.515 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.2 t80 -61.81 129.96 43.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 111.04 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -90.64 104.23 8.68 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.778 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.6 Cg_exo -73.51 -32.97 7.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 113.052 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.55 32.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.704 HG22 ' OG1' ' A' ' 8' ' ' THR . 24.4 m -82.77 -30.06 29.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.418 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.03 31.84 24.99 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.874 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.704 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -118.51 -137.2 0.35 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.27 9.86 2.52 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.543 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.102 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.526 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 34.9 t80 -70.91 155.4 40.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.234 0.54 . . . . 0.0 111.06 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -120.03 80.48 26.67 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.357 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.42 -26.29 27.62 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 113.082 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.53 -55.27 36.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.076 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.55 HG22 ' OG1' ' A' ' 8' ' ' THR . 5.0 m -94.59 -24.24 17.3 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.75 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.11 31.72 13.91 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.801 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.55 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -118.27 -137.46 0.35 Allowed 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 18.8 m-85 -137.35 10.59 2.98 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.545 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.552 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.553 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.0 t80 -59.7 128.37 36.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.651 0.262 . . . . 0.0 111.059 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -86.66 104.36 5.68 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 17.3 Cg_exo -70.91 -33.02 12.84 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.556 2.171 . . . . 0.0 113.044 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.75 41.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.964 0.412 . . . . 0.0 110.701 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.751 HG22 ' OG1' ' A' ' 8' ' ' THR . 18.2 m -85.02 -29.72 24.74 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.64 31.51 29.81 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.911 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.751 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.3 OUTLIER -123.85 -137.55 0.29 Allowed 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.45 6.81 3.83 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.249 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.288 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.579 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.522 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.3 t80 -60.78 129.72 42.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.767 0.318 . . . . 0.0 110.969 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.4 104.15 8.3 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.889 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.3 Cg_exo -73.48 -32.99 7.34 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.764 2.31 . . . . 0.0 113.005 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.82 -55.36 35.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.75 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.671 HG22 ' OG1' ' A' ' 8' ' ' THR . 28.3 m -83.97 -30.63 26.07 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.399 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 33.09 22.67 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.975 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.671 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.17 -138.05 0.36 Allowed 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -140.38 10.46 2.3 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.483 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.434 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.511 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 83.3 t80 -61.23 129.68 42.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.734 0.302 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -90.95 104.32 9.16 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.775 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.2 Cg_exo -73.74 -33.01 6.91 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.657 2.238 . . . . 0.0 112.964 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.4 -55.76 29.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 110.731 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.677 HG22 ' OG1' ' A' ' 8' ' ' THR . 32.5 m -81.93 -30.71 31.66 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.357 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.38 24.78 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.159 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.677 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -117.34 -137.49 0.36 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -139.01 10.28 2.59 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.608 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.066 0 CA-C-N 114.493 -1.23 . . . . 0.0 112.454 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.534 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.8 t80 -60.21 129.05 39.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.681 0.277 . . . . 0.0 111.014 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.36 104.46 6.35 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.532 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 17.1 Cg_exo -72.48 -31.82 10.7 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.629 2.219 . . . . 0.0 113.182 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.74 -54.18 50.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.593 HG22 ' OG1' ' A' ' 8' ' ' THR . 8.9 m -93.67 -25.73 17.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.53 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.35 33.28 14.38 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.826 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -116.29 -138.57 0.37 Allowed 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.348 0.594 . . . . 0.0 109.493 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.75 6.58 3.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.378 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.095 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.413 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.533 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 85.6 t80 -61.54 129.52 41.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.688 0.28 . . . . 0.0 111.042 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.49 104.12 7.42 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.769 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.9 Cg_exo -73.08 -32.69 8.31 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.725 2.283 . . . . 0.0 113.126 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -56.02 27.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 110.646 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.663 HG22 ' OG1' ' A' ' 8' ' ' THR . 21.8 m -85.49 -29.46 24.25 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.393 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.7 32.3 22.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.97 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.663 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -117.18 -137.28 0.36 Allowed 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.14 10.01 2.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.123 0 CA-C-O 118.333 -1.26 . . . . 0.0 112.54 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.505 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 82.0 t80 -60.52 129.57 42.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.733 0.301 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -91.77 104.24 9.88 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.846 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.4 Cg_exo -74.09 -32.78 6.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.822 2.348 . . . . 0.0 113.047 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.75 -55.42 34.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.706 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.58 HG22 ' OG1' ' A' ' 8' ' ' THR . 20.0 m -86.17 -28.74 23.75 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.439 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 33.69 18.28 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.078 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.58 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -113.18 -138.0 0.37 Allowed 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -139.79 10.89 2.45 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.7 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.129 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.465 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.524 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.7 t80 -62.46 129.74 42.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.71 0.29 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -90.29 104.07 8.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.848 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.5 Cg_exo -73.31 -33.1 7.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.619 2.213 . . . . 0.0 112.982 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.14 -54.86 40.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.719 HG22 ' OG1' ' A' ' 8' ' ' THR . 22.5 m -83.71 -30.34 26.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.421 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.97 32.09 24.54 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.995 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.719 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -119.0 -137.18 0.34 Allowed 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -139.39 9.51 2.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.457 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.073 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.445 179.952 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.528 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.5 t80 -63.69 129.77 41.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.627 0.251 . . . . 0.0 111.044 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -89.86 104.1 7.7 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.77 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 15.3 Cg_exo -73.71 -32.37 7.61 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.767 2.311 . . . . 0.0 113.288 -178.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -54.59 45.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.566 HG22 ' OG1' ' A' ' 8' ' ' THR . 6.1 m -92.83 -24.84 18.37 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.597 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.43 34.72 15.93 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.819 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.566 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -110.95 -137.86 0.37 Allowed 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 12.3 m-85 -144.25 10.25 1.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.556 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.121 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.495 179.995 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 84.1 t80 -62.03 129.76 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.754 0.312 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.92 104.13 8.69 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.848 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 14.9 Cg_exo -73.73 -32.79 7.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.674 2.25 . . . . 0.0 113.094 -178.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.65 -55.59 32.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.701 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.61 HG22 ' OG1' ' A' ' 8' ' ' THR . 24.6 m -84.92 -30.01 24.7 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.385 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.32 33.29 20.47 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.61 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -115.13 -137.9 0.37 Allowed 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.618 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -140.13 10.23 2.35 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.599 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.169 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.484 179.969 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 30.7 t80 -70.83 152.85 43.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.211 0.529 . . . . 0.0 111.061 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -119.2 80.75 20.3 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.183 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.32 -26.89 28.85 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.496 2.131 . . . . 0.0 112.865 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.96 38.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.881 0.372 . . . . 0.0 111.221 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.608 HG22 ' OG1' ' A' ' 8' ' ' THR . 7.7 m -90.77 -25.6 19.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.92 16.85 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.872 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -120.32 -137.53 0.33 Allowed 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.877 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 2' ' ' TYR . 15.5 m-85 -136.25 10.29 3.25 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.508 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.093 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.464 179.986 . . . . . . . . 0 0 . 1 stop_ save_